Recovery of baseline lung function after pulmonary exacerbation in children with primary ciliary dyskinesia

Area of Science:

• Pediatric Pulmonology
• Respiratory Medicine
• Genetics and Rare Diseases

Background:

• Pulmonary exacerbations in children with cystic fibrosis (CF) often result in persistent lung function deficits.
• It remains unclear if children with primary ciliary dyskinesia (PCD) experience similar long-term effects on lung function after exacerbations.

Purpose of the Study:

• To determine the proportion of children with PCD who recover baseline spirometry (forced expiratory volume in 1 second - FEV1) within three months post-treatment for a pulmonary exacerbation.
• To identify factors associated with the failure to regain pre-exacerbation FEV1 in pediatric PCD patients.

Main Methods:

• A cohort study was conducted using data from the PCD database at the Royal Brompton Hospital (2003-2013).
• The study analyzed the first pulmonary exacerbation treated with intravenous antibiotics in pediatric patients.
• Baseline FEV1 (best FEV1 in the 12 months prior) was compared to post-treatment FEV1 (best FEV1 within 3 months), with recovery defined as >=90% of baseline.

Main Results:

• Out of 150 children, 32 (21%) experienced at least one pulmonary exacerbation.
• Of the 30 children analyzed for recovery, 23 (77%) regained baseline spirometry within three months.
• No significant differences in baseline characteristics were observed between patients who recovered and those who did not.

Conclusions:

• Approximately 25% of children with PCD do not achieve baseline lung function within three months after treatment for a pulmonary exacerbation, mirroring outcomes seen in CF.
• The findings highlight the need for enhanced treatment strategies for PCD pulmonary exacerbations.
• Preventing exacerbations may serve as a valuable endpoint in future clinical trials for PCD.